The proposed Medicare High-Value Drug List Model, also known as the Medicare $2 Drug List, could have modestly reduced out-of ...

New findings add to the understanding of the patient experience in axial spondyloarthritis (axSpA), which can help inform ...

On day 1 of the Family Heart Global Summit, speakers highlighted the critical need for awareness, early diagnosis, and ...

World Dense Breast Day emphasizes the need for awareness and advocacy for individuals with dense breasts, which can ...

"As CMMI continues to test new equity adjustments, it is important that changes be grounded in scientific principles with ...

How do guidelines from professional organizations, including ACC, AHA, ADA, KDIGO, ACE, and DCRMi, address the management and interconnectivity of CRM conditions? How have these guidelines evolved in ...

Experts in cardiometabolic risk management examine the factors contributing to low adherence to guidelines for cardiometabolic conditions, with a specific focus on type 2 diabetes.

New research highlights increased stroke, heart attack, and heart failure risks in cancer survivors, especially those treated ...

Demonstration projects to show accurate use of artificial intelligence (AI) in cancer care are important to prevent a loss of ...

Isatuximab (Sarclisa) with bortezomib, lenalidomide, and dexamethasone (VRd) is now an approved option for adults who cannot ...

A new study demonstrates that the combination of lenalidomide (Revlimid) and obinutuzumab (Gazyva) is effective and ...

Researchers developed a pan-immune-inflammation–based nomogram to accurately predict overall survival (OS) and ...